athenahealth, Inc. (NASDAQ:ATHN) Given Consensus Recommendation of “Hold” by Analysts
Shares of athenahealth, Inc. (NASDAQ:ATHN) have earned a consensus recommendation of “Hold” from the twenty-eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation and thirteen have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $148.05.
ATHN has been the subject of several research reports. William Blair reissued a “market perform” rating on shares of athenahealth in a research report on Friday. Cantor Fitzgerald restated a “buy” rating and issued a $118.00 price target (down previously from $135.00) on shares of athenahealth in a research note on Thursday, April 27th. Piper Jaffray Companies restated an “overweight” rating and issued a $160.00 price target on shares of athenahealth in a research note on Tuesday, April 4th. Argus started coverage on athenahealth in a research note on Friday, July 7th. They issued a “hold” rating on the stock. Finally, Citigroup Inc. restated a “buy” rating and issued a $163.00 price target (up previously from $128.00) on shares of athenahealth in a research note on Monday, June 5th.
Shares of athenahealth (ATHN) traded down 1.0904% on Tuesday, hitting $153.1417. The company had a trading volume of 164,477 shares. The stock has a market capitalization of $6.11 billion, a PE ratio of 194.3423 and a beta of 1.79. athenahealth has a 52 week low of $90.11 and a 52 week high of $156.84. The firm’s 50 day moving average price is $142.47 and its 200-day moving average price is $123.33.
athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The firm had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. During the same quarter in the prior year, the company earned $0.34 EPS. The business’s revenue was up 15.0% compared to the same quarter last year. Analysts forecast that athenahealth will post $1.90 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This piece was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/07/25/athenahealth-inc-nasdaqathn-given-consensus-recommendation-of-hold-by-analysts.html.
In other news, CFO Karl Stubelis sold 3,952 shares of the firm’s stock in a transaction on Monday, June 5th. The stock was sold at an average price of $138.98, for a total value of $549,248.96. Following the transaction, the chief financial officer now directly owns 21,810 shares in the company, valued at approximately $3,031,153.80. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Jonathan D. Porter sold 422 shares of the firm’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $154.00, for a total value of $64,988.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 18,105 shares of company stock worth $2,434,859. Company insiders own 3.20% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in the company. Huntington National Bank increased its position in athenahealth by 7.7% in the second quarter. Huntington National Bank now owns 55,848 shares of the health services provider’s stock worth $7,850,000 after buying an additional 4,010 shares during the period. Aperio Group LLC boosted its position in shares of athenahealth by 10.6% in the second quarter. Aperio Group LLC now owns 6,709 shares of the health services provider’s stock worth $943,000 after buying an additional 641 shares in the last quarter. Cribstone Capital Management LLC boosted its position in shares of athenahealth by 3.3% in the second quarter. Cribstone Capital Management LLC now owns 14,186 shares of the health services provider’s stock worth $1,994,000 after buying an additional 452 shares in the last quarter. CrestPoint Capital Management LLC bought a new position in shares of athenahealth during the second quarter worth approximately $337,000. Finally, Clearbridge Investments LLC boosted its position in shares of athenahealth by 61.8% in the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock worth $102,379,000 after buying an additional 347,133 shares in the last quarter.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.